🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Enanta Pharmaceuticals, Inc.

ENTA Healthcare
$13.34 +$0.12 (0.91%)
Market Cap: $387.91 M
Gurus Holding
3
Popularity Rank
#2721
% of Shares Held
3.40%
Net Activity (Q1 2026)
-$5.51 M

Guru Ownership Trend

Guru Analysis for Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals, Inc. (ENTA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $13.19 M.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $5.51 M net outflow during the quarter.

Recent activity highlights Paul Tudor Jones who opened a new position.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$1.41 M
Total Buy Value
New Buys 1
Additions 2
-$6.92 M
Total Sell Value
Reductions 0
Sold Out 1

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
1
Net Buyers
3

FAQs for Enanta Pharmaceuticals, Inc. (ENTA)

Major holders include Renaissance Technologies (RenTech) ($8.4 M), Cliff Asness ($3.96 M), Paul Tudor Jones ($131,112). According to the latest reported data, 3 tracked investment managers collectively hold approximately 988,796 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $5.51 M, with 3 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited ENTA. The total reported sell value was $6.92 M.

Yes, 1 managers opened new positions in ENTA, and 2 increased their existing holdings. The total reported buy value was $1.41 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Add 3.6% 665,258 $8.4 M Q1 2026
0.00% Add 33.4% 313,157 $3.96 M Q1 2026
0.00% New Buy 10,381 $131,112 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form